INBRX-130, a 5T4-Targeted CONTRA-MAB, is a Potent CD3 Bispecific Antibody Engineered to Have Minimal Off-Tumor ActivityKatelyn M. Willis, Margaret Haerr, Marchelle Meza,Sae Jeong Ahn, Michael Kaplan, Georgina Ortiz-Barquero,Rajay Pandit, Rafael Abalos, Yao Chen, Samuel Holley,Raul Lozano, Iljin Hwang,Emily Rowell,Brendan P. EckelmanCANCER RESEARCH（2022）引用 0|浏览5AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
